Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06420206

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Ahmed Elsayem, MD,MPH

CONTACT

[email protected]

713-745-9911

Ahmed Elsayem, MD,MPH

PRINCIPAL_INVESTIGATOR

About this study

Primary Objective:

To compare overall percentage of days spent in an acute care setting over the 30-day period from time of the index emergency department (ED), referred to as Acute Cancer Care Center (ACCC), visit for patients who receive the emergency department-based GOC intervention and those who do not.

Secondary Objective:

To obtain data on rates of admission to the ICU, death in the hospital setting, symptom improvement for participants hospitalized, hospice referral, survival, and 30-day care costs for participants who receive the GOC intervention in the ACCC and those who do not.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment
  • Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available.
  • Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
  • Participant has the ability to speak and write in English
  • Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent

Exclusion criteria

  • Participant is already enrolled in hospice
  • Participant is comatose
  • Participant has severe intellectual disability
  • Participant has a history of dementia documented in the medical records
  • Participant has baseline communication barriers such as aphasia or deafness
  • Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival
  • Participant is 18 years or older, currently cared for by pediatrics service
  • Pregnant women
  • Prisoners

Treatment and study plan

Standard of Care (Acute Cancer Care Center)

Other

In Group 1, participants will receive the usual standard of care by an emergency care physician not trained in palliative care.

Standard of Care (Goals of Care)

Other

In Group 2, participants will receive standard of care plus palliative care intervention by an emergency care physician trained in palliative care.

Primary outcomes

  1. Quality Of Life Questionnaire

    Time frame: through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Elsayem, MD,MPH

CONTACT

[email protected]

(713) 745-9911

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
May 17, 2024
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.